Regulation of interleukin-6 expression in osteoblasts by oxidized phospholipids

Journal of Lipid Research

Volumn 51, Issue 5, 2010, Pages 1010-1016

  Tseng, Wendy ^a   Lu, Jinxiu ^b   Bishop, Gail A ^d,e   Watson, Andrew D ^a   Sage, Andrew P ^a   Demer, Linda ^a,b,c   Tintut, Yin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of California   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Calvaria; Cytokines; Inflammation; Lipids; Osteoporosis

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; INTERLEUKIN 6; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; OXIDIZED PALMITOYL 2 ARACHIDONYL SN GLYCERO 3 PHOSPHOCHOLINE; PHOSPHOLIPID DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALVARIA; CELL LEVEL; CONTROLLED STUDY; DELETION MUTANT; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE LOCATION; HYPERLIPIDEMIA; LIPID ANALYSIS; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION; WILD TYPE;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE; GENE EXPRESSION REGULATION; INTERLEUKIN-6; INTRACELLULAR SPACE; MICE; OSTEOBLASTS; OXIDATION-REDUCTION; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; RESPONSE ELEMENTS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 77951047789     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M001099     Document Type: Article

References (33)

1. Hamerman, D. 2005. Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies. QJM. 98: 467-484.
2. Yamaguchi, T., T. Sugimoto, S. Yano, M. Yamauchi, H. Sowa, Q. Chen, and K. Chihara. 2002. Plasma lipids and osteoporosis in postmenopausal women. Endocr. J. 49: 211-217. (Pubitemid 34496340)
3. Poli, A., F. Bruschi, B. Cesana, M. Rossi, R. Paoletti, and P. G. Crosignani. 2003. Plasma low-density lipoprotein cholesterol and bone mass densitometry in postmenopausal women. Obstet. Gynecol. 102: 922-926.
4. Hirasawa, H., S. Tanaka, A. Sakai, M. Tsutsui, H. Shimokawa, H. Miyata, S. Moriwaki, S. Niida, M. Ito, and T. Nakamura. 2007. ApoE gene deficiency enhances the reduction of bone formation induced by a high-fat diet through the stimulation of p53-mediated apoptosis in osteoblastic cells. J. Bone Miner. Res. 22: 1020-1030.
5. Parhami, F., Y. Tintut, W. G. Beamer, N. Gharavi, W. Goodman, and L. L. Demer. 2001. Atherogenic high-fat diet reduces bone mineralization in mice. J. Bone Miner. Res. 16: 182-188.
6. Tintut, Y., S. Morony, and L. L. Demer. 2004. Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler. Thromb. Vasc. Biol. 24: e6-e10.
7. Tintut, Y., F. Parhami, A. Tsingotjidou, S. Tetradis, M. Territo, and L. L. Demer. 2002. 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J. Biol. Chem. 277: 14221-14226.
8. Van Lenten, B. J., A. C. Wagner, M. Navab, and A. M. Fogelman. 2001. Oxidized phospholipids induce changes in hepatic paraoxonase and ApoJ but not monocyte chemoattractant protein-1 via interleukin-6. J. Biol. Chem. 276: 1923-1929.
9. Yeh, M., N. Leitinger, R. de Martin, N. Onai, K. Matsushima, D. K. Vora, J. A. Berliner, and S. T. Reddy. 2001. Increased transcription of IL-8 in endothelial cells is differentially regulated by TNF-alpha and oxidized phospholipids. Arterioscler. Thromb. Vasc. Biol. 21: 1585-1591.
10. Al-Aly, Z., J. S. Shao, C. F. Lai, E. Huang, J. Cai, A. Behrmann, S. L. Cheng, and D. A. Towler. 2007. Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice. Arterioscler. Thromb. Vasc. Biol. 27: 2589-2596.
11. Furnkranz, A., A. Schober, V. N. Bochkov, P. Bashtrykov, G. Kronke, A. Kadl, B. R. Binder, C. Weber, and N. Leitinger. 2005. Oxidized phospholipids trigger atherogenic inflammation in murine arteries. Arterioscler. Thromb. Vasc. Biol. 25: 633-638.
12. Watson, A. D., N. Leitinger, M. Navab, K. F. Faull, S. Horkko, J. L. Witztum, W. Palinski, D. Schwenke, R. G. Salomon, W. Sha, et al. 1997. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272: 13597-13607.
13. Brodeur, M. R., L. Brissette, L. Falstrault, P. Ouellet, and R. Moreau. 2008. Influence of oxidized low-density lipoproteins (LDL) on the viability of osteoblastic cells. Free Radic. Biol. Med. 44: 506-517. (Pubitemid 351181262)
14. Pfeilschifter, J., R. Koditz, M. Pfohl, and H. Schatz. 2002. Changes in proinflammatory cytokine activity after menopause. Endocr. Rev. 23: 90-119. (Pubitemid 34185307)
15. Ishimi, Y., C. Miyaura, C. H. Jin, T. Akatsu, E. Abe, Y. Nakamura, A. Yamaguchi, S. Yoshiki, T. Matsuda, T. Hirano, et al. 1990. IL-6 is produced by osteoblasts and induces bone resorption. J. Immunol. 145: 3297-3303.
16. Grey, A., M. A. Mitnick, U. Masiukiewicz, B. H. Sun, S. Rudikoff, R. L. Jilka, S. C. Manolagas, and K. Insogna. 1999. A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo. Endocrinology. 140: 4683-4690.
17. Insogna, K., M. Mitnick, J. Pascarella, I. Nakchbandi, A. Grey, and U. Masiukiewicz. 2002. Role of the interleukin-6/interleukin-6 soluble receptor cytokine system in mediating increased skeletal sensitivity to parathyroid hormone in perimenopausal women. J. Bone Miner. Res. 17(Suppl 2): N108-N116. (Pubitemid 35222322)
18. Masiukiewicz, U. S., M. Mitnick, B. I. Gulanski, and K. L. Insogna. 2002. Evidence that the IL-6/IL-6 soluble receptor cytokine system plays a role in the increased skeletal sensitivity to PTH in estrogen-deficient women. J. Clin. Endocrinol. Metab. 87: 2892-2898. (Pubitemid 34655359)
19. Rodan, G. A. 1992. Introduction to bone biology. Bone. 13(Suppl 1): S3-S6.
20. Watson, A. D., G. Subbanagounder, D. S. Welsbie, K. F. Faull, M. Navab, M. E. Jung, A. M. Fogelman, and J. A. Berliner. 1999. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein. J. Biol. Chem. 274: 24787-24798. (Pubitemid 129529366)
21. Nervina, J. M., C. E. Magyar, F. Q. Pirih, and S. Tetradis. 2006. PGC-1alpha is induced by parathyroid hormone and coactivates Nurr1-mediated promoter activity in osteoblasts. Bone. 39: 1018-1025.
22. Baccam, M., S. Y. Woo, C. Vinson, and G. A. Bishop. 2003. CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-kappa B, AP-1, and C/EBP. J. Immunol. 170: 3099-3108.
23. Bordin, L., G. Priante, E. Musacchio, S. Giunco, E. Tibaldi, G. Clari, and B. Baggio. 2003. Arachidonic acid-induced IL-6 expression is mediated by PKC alpha activation in osteoblastic cells. Biochemistry. 42: 4485-4491.
24. Birukov, K. G., N. Leitinger, V. N. Bochkov, and J. G. Garcia. 2004. Signal transduction pathways activated in human pulmonary endothelial cells by OxPAPC, a bioactive component of oxidized lipoproteins. Microvasc. Res. 67: 18-28.
25. Cole, A. L., G. Subbanagounder, S. Mukhopadhyay, J. A. Berliner, and D. K. Vora. 2003. Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/PI3-kinase pathway. Arterioscler. Thromb. Vasc. Biol. 23: 1384-1390.
26. Parhami, F., Z. T. Fang, A. M. Fogelman, A. Andalibi, M. C. Territo, and J. A. Berliner. 1993. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J. Clin. Invest. 92: 471-478.
27. Hershko, D. D., B. W. Robb, G. Luo, and P. O. Hasselgren. 2002. Multiple transcription factors regulating the IL-6 gene are activated by cAMP in cultured Caco-2 cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283: R1140-R1148.
28. Chen, C., A. J. Koh, N. S. Datta, J. Zhang, E. T. Keller, G. Xiao, R. T. Franceschi, N. J. D'Silva, and L. K. McCauley. 2004. Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts. J. Biol. Chem. 279: 29121-29129.
29. Davies, S. P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351: 95-105.
30. Radeff, J. M., Z. Nagy, and P. H. Stern. 2004. Rho and Rho kinase are involved in parathyroid hormone-stimulated protein kinase C alpha translocation and IL-6 promoter activity in osteoblastic cells. J. Bone Miner. Res. 19: 1882-1891.
31. Motomura, T., S. Kasayama, M. Takagi, S. Kurebayashi, H. Matsui, T. Hirose, Y. Miyashita, K. Yamauchi-Takihara, T. Yamamoto, S. Okada, et al. 1998. Increased interleukin-6 production in mouse osteoblastic MC3T3-E1 cells expressing activating mutant of the stimulatory G protein. J. Bone Miner. Res. 13: 1084-1091.
32. Parhami, F., A. D. Morrow, J. Balucan, N. Leitinger, A. D. Watson, Y. Tintut, J. A. Berliner, and L. L. Demer. 1997. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler. Thromb. Vasc. Biol. 17: 680-687.
33. Nerland, D. E. 2007. The antioxidant/electrophile response element motif. Drug Metab. Rev. 39: 235-248.